MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $945,030 | +106.3% | 20,857 | +218.2% | 0.00% | 0.0% |
| Q3 2022 | $458,000 | +28.7% | 6,555 | +51.2% | 0.00% | – |
| Q1 2022 | $356,000 | -95.2% | 4,335 | -91.5% | 0.00% | -100.0% |
| Q4 2021 | $7,443,000 | +1043.3% | 50,740 | +1159.4% | 0.01% | +600.0% |
| Q2 2021 | $651,000 | -87.5% | 4,029 | -86.7% | 0.00% | -83.3% |
| Q1 2021 | $5,201,000 | +39.1% | 30,360 | +78.3% | 0.01% | +20.0% |
| Q4 2020 | $3,740,000 | +161.9% | 17,028 | +98.0% | 0.01% | +150.0% |
| Q3 2020 | $1,428,000 | -28.1% | 8,599 | -66.7% | 0.00% | -60.0% |
| Q1 2020 | $1,987,000 | -0.1% | 25,853 | +1.2% | 0.01% | +25.0% |
| Q3 2019 | $1,989,000 | – | 25,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |